[Webinar] Results from Phase I/II HOPE Clinical Trial of CAP-1002 - April 2017

Capricor Therapeutics: CAP-1002 HOPE-3 Program UpdateПодробнее

[Webinar] Capricor's Clinical Program - April 2019Подробнее

Late Breaking News: Capricor / Cap-1002 -- PPMD 2022 Annual ConferenceПодробнее

Trial Update: CAP-1002 - Capricor [PPMD's 2017 Connect Conference]Подробнее

[Webinar] MoveDMD: A Clinical Trial of Edasalonexent (CAT-1004) in Duchenne - June 2016Подробнее

[Webinar] HOPE-2 Duchenne Clinical Trial – Capricor – July 2018Подробнее

HOPE-Duchenne Trial - Capricor Therapeutics [January 2016 Webinar]Подробнее

Webinar: Capricor's HOPE-2 Final 12-Month Data (June 2020)Подробнее

[Webinar] Capricor's HOPE-2 Interim Analysis - July 2019Подробнее

[Webinar] Akashi Provides Update on HT-100 - March 2017Подробнее

2023 CR Forum Top Ten| Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients with HOPE-2)Подробнее

Phase II Clinical Trial Development for Tivatinib (ARQ 197) in GI CancersПодробнее

Phase I - II ConsiderationsПодробнее

[Webinar] Vamorolone (VBP15) Clinical Trials in Duchenne - January 2017Подробнее

[Webinar] Givinostat in Duchenne - April 2017Подробнее

Webinar: Capricor Data Update From Ongoing HOPE-2 Open Label Extension Trial (Jan 2023)Подробнее

HOPE-Duchenne Clinical TrialПодробнее